Tyra Biosciences, Inc.

19.18 USD
-0.05 (-0.26%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tyra Biosciences, Inc. stock is up 43.46% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 11 February’s closed higher than January.

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc. focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer.